Like you, we have been closely monitoring the COVID-19 pandemic. We are all experiencing some uncertainty about the near to mid-term future.
We wanted to take this opportunity to reassure you that Empirical Bioscience is considered an essential business and is still operating at full capacity. We have developed a preparedness and infection control plan in the event of employee illness or absence. The safety of our employees is of the greatest importance to us, and we are abiding by CDC guidelines.
If our operations are affected significantly, we will inform you of the impact and any effects it will have on our services.
To-date we have not experienced any significant supply shortages. Our staff is working with our supply chain vendors so that we can be well positioned to overcome any future challenges if they should arise. We will keep you informed through normal communications channels if there are any changes that may affect your projects.
The work we collectively do in the life sciences field is more important now than ever before. If you have any questions or concerns, please don’t hesitate to contact us through your regular project communication channels, or email us at email@example.com